Altered distribution of basic fibroblast growth factor in diabetic retinopathy

A. Hanneken, E. de Juan Jr, G. A. Lutty, G. M. Fox, S. Schiffer and L. M. Hjelmeland
Department of Molecular and Cellular Growth Biology, Whittier Institute for Diabetes and Endocrinology, La Jolla, Calif 92037.

Basic fibroblast growth factor (FGF) is a potent endothelial cell mitogen that has been proposed to play a role in proliferative diabetic retinopathy and other neovascular processes. Our understanding of the in vivo role of basic FGF in the pathogenesis of these disorders is limited. We studied the immunolocalization of basic FGF in 16 clinical cases of diabetic retinopathy to determine whether the normal retinal distribution of basic FGF changed during the development of diabetic retinopathy and correlated with the onset of retinal neovascularization. By using monoclonal and affinity-purified polyclonal antibodies against basic FGF and heparan sulfate proteoglycan (HSPG), we found that basic FGF colocalized with HSPG to vascular basement membranes. As the basement membranes thickened during the progression of diabetic retinopathy, the intraretinal stores of immunoreactive basic FGF and HSPG expanded. With the development of neovascularization, the colocalization of basic FGF and HSPG changed; HSPG localized to basement membranes, while basic FGF localized intracellularly, with only minimal basement membrane immunoreactivity. Incubations of the neovascular fronds with exogenous basic FGF demonstrated multiple HSPG glycosaminoglycan-binding sites for basic FGF, indicating that basic FGF had not been released from the matrix of neovascular fronds by heparitanase digestion.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glucose Modulates Basement Membrane Fibroblast Growth Factor-2 via Alterations in Endothelial Cell Permeability
Morss and Edelman
J. Biol. Chem. 2007;282:14635-14644.
ABSTRACT | FULL TEXT  

Expression of Pigment Epithelium-Derived Factor in Normal Adult Rat Eye and Experimental Choroidal Neovascularization
Ogata et al.
IOVS 2002;43:1168-1175.
ABSTRACT | FULL TEXT  

Angiogenic factors in human proliferative sickle cell retinopathy
Cao et al.
Br. J. Ophthalmol. 1999;83:838-846.
ABSTRACT | FULL TEXT  

Growth factor staining patterns in the pig retina following retinal laser photocoagulation
Xiao et al.
Br. J. Ophthalmol. 1999;83:728-736.
ABSTRACT | FULL TEXT  

Basic Fibroblast Growth Factor Is Neither Necessary nor Sufficient for the Development of Retinal Neovascularization
Ozaki et al.
Am. J. Pathol. 1998;153:757-765.
ABSTRACT | FULL TEXT  

VEGF localisation in diabetic retinopathy
Boulton et al.
Br. J. Ophthalmol. 1998;82:561-568.
ABSTRACT | FULL TEXT  

Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes
Chen et al.
Br. J. Ophthalmol. 1997;81:919-926.
ABSTRACT | FULL TEXT  

Increased Levels of Serum Fibroblast Growth Factor-2 in Diabetic Pregnant Women with Retinopathy
Hill et al.
J. Clin. Endocrinol. Metab. 1997;82:1452-1457.
ABSTRACT | FULL TEXT  

The Biology of Vascular Endothelial Growth Factor
Ferrara and Davis-Smyth
Endocr. Rev. 1997;18:4-25.
ABSTRACT | FULL TEXT  

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Aiello et al.
NEJM 1994;331:1480-1487.
ABSTRACT | FULL TEXT  

Vascular Endothelial Growth Factor -- Its Role in Retinal Vascular Proliferation
Frank
NEJM 1994;331:1519-1520.
FULL TEXT